Physician profile
Todd Nguyen
NPI 1063270015
$383.28
in general payments reported to CMS, 2019-2025
8 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $140.70 | 2025 | Korlym |
| Lilly USA, LLC | $58.02 | 2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $45.02 | 2025 | Bexsero, Shingrix, Arexvy |
| Indivior INC. | $34.50 | 2025 | Sublocade |
| Novo Nordisk INC | $31.91 | 2025 | Wegovy |
| Viiv Healthcare Company | $27.69 | 2025 | Cabenuva |
| Gilead Sciences, INC. | $25.51 | 2025 | Yeztugo |
| Merck Sharp & Dohme LLC | $19.93 | 2025 | Gardasil 9, M-M-R II, Enflonsia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.